|
1
|
Zeng YJ, Zhang CD and Dai DQ: Impact of
lymph node micrometastasis on gastric carcinoma prognosis: A
meta-analysis. World J Gastroenterol. 21:1628–1635. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Vilaseca Cabo A, Musquera Felip M, Ribal
Caparros MJ and Alcaraz Asensio A: Metastasis of gastric carcinoma
simulating a urothelial tumor. Case report and review of the
literature. Arch Esp Urol. 66:885–889. 2013.(In English, Spanish).
PubMed/NCBI
|
|
3
|
Micolucci L, Akhtar MM, Olivieri F, Rippo
MR and Procopio AD: Diagnostic value of microRNAs in asbestos
exposure and malignant mesothelioma: Systematic review and
qualitative meta-analysis. Oncotarget. 7:58606–58637. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jiang L, Huang J, Chen Y, Yang Y, Li R, Li
Y, Chen X and Yang D: Identification of several circulating
microRNAs from a genome-wide circulating microRNA expression
profile as potential biomarkers for impaired glucose metabolism in
polycystic ovarian syndrome. Endocrine. 53:280–290. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hansen TF, Andersen CL, Nielsen BS,
Spindler KL, Sørensen FB, Lindebjerg J, Brandslund I and Jakobsen
A: Elevated microRNA-126 is associated with high vascular
endothelial growth factor receptor 2 expression levels and high
microvessel density in colorectal cancer. Oncol Lett. 2:1101–1106.
2011.PubMed/NCBI
|
|
6
|
Liu C, Wang C, Wang J and Huang H:
miR-1297 promotes cell proliferation by inhibiting RB1 in liver
cancer. Oncol Lett. 12:5177–5182. 2016.PubMed/NCBI
|
|
7
|
Mataki H, Enokida H, Chiyomaru T, Mizuno
K, Matsushita R, Goto Y, Nishikawa R, Higashimoto I, Samukawa T,
Nakagawa M, et al: Downregulation of the microRNA-1/133a cluster
enhances cancer cell migration and invasion in lung-squamous cell
carcinoma via regulation of Coronin1C. J Hum Genet. 60:53–61. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ming J, Zhou Y, Du J, Fan S, Pan B, Wang
Y, Fan L and Jiang J: miR-381 suppresses C/EBPα-dependent Cx43
expression in breast cancer cells. Biosci Rep. 35:pii: e00266.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tzeng HE, Chang AC, Tsai CH, Wang SW and
Tang CH: Basic fibroblast growth factor promotes VEGF-C-dependent
lymphangiogenesis via inhibition of miR-381 in human chondrosarcoma
cells. Oncotarget. 7:38566–38578. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li Y, Zhao C, Yu Z, Chen J, She X, Li P,
Liu C, Zhang Y, Feng J, Fu H, et al: Low expression of miR-381 is a
favorite prognosis factor and enhances the chemosensitivity of
osteosarcoma. Oncotarget. 7:68585–68596. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xia B, Li H, Yang S, Liu T and Lou G:
MiR-381 inhibits epithelial ovarian cancer malignancy via YY1
suppression. Tumour Biol. 37:9157–9167. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bayoumi AS, Sayed A, Broskova Z, Teoh JP,
Wilson J, Su H, Tang YL and Kim IM: Crosstalk between long
noncoding RNAs and MicroRNAs in health and disease. Int J Mol Sci.
17:3562016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li C, Yang W, Zhang J, Zheng X, Yao Y, Tu
K and Liu Q: SREBP-1 has a prognostic role and contributes to
invasion and metastasis in human hepatocellular carcinoma. Int J
Mol Sci. 15:7124–7138. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wei WJ, Shen CT, Song HJ, Qiu ZL and Luo
QY: MicroRNAs as a potential tool in the differential diagnosis of
thyroid cancer: A systematic review and meta-analysis. Clin
Endocrinol (Oxf). 84:127–133. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang L, Wang YX, Chen LP and Ji ML:
Upregulation of microRNA-181b inhibits CCL18-induced breast cancer
cell metastasis and invasion via the NF-κB signaling pathway. Oncol
Lett. 12:4411–4418. 2016.PubMed/NCBI
|
|
16
|
Ma YJ, Ha CF, Bai ZM, Li HN, Xiong Y and
Jiang J: Overexpression of microRNA-205 predicts lymph node
metastasis and indicates an unfavorable prognosis in endometrial
cancer. Oncol Lett. 12:4403–4410. 2016.PubMed/NCBI
|
|
17
|
Liang Y, Zhao Q, Fan L, Zhang Z, Tan B,
Liu Y and Li Y: Downregulatedtion of MicroRNA-381 promotes cell
proliferation and invasion in colon cancer through upregulatedtion
of LRH-1. Biomed Pharmacother. 75:137–141. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen B, Duan L, Yin G, Tan J and Jiang X:
miR-381, a novel intrinsic WEE1 inhibitor, sensitizes renal cancer
cells to 5-FU by upregulatedtion of Cdc2 activities in 786-O. J
Chemother. 25:229–238. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang Z, Yang J, Xu G, Wang W, Liu C, Yang
H, Yu Z, Lei Q, Xiao L, Xiong J, et al: Targeting miR-381-NEFL axis
sensitizes glioblastoma cells to temozolomide by regulating
stemness factors and multidrug resistance factors. Oncotarget.
6:3147–3164. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yeung KT and Yang J:
Epithelial-mesenchymal transition in tumor metastasis. Mol Oncol.
11:28–39. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Parvani JG and Schiemann WP: Sox4, EMT
programs, and the metastatic progression of breast cancers:
Mastering the masters of EMT. Breast Cancer Res. 15:R722013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li Y, Chen P, Zu L, Liu B, Wang M and Zhou
Q: MicroRNA-338-3p suppresses metastasis of lung cancer cells by
targeting the EMT regulator Sox4. Am J Cancer Res. 6:127–140.
2016.PubMed/NCBI
|
|
23
|
Fu W, Tao T, Qi M, Wang L, Hu J, Li X,
Xing N, Du R and Han B: MicroRNA-132/212 upregulation inhibits
TGF-β-Mediated epithelial-mesenchymal transition of prostate cancer
cells by targeting SOX4. Prostate. 76:1560–1570. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ji TT, Huang X, Jin J, Pan SH and Zhuge
XJ: Inhibition of long non-coding RNA TUG1 on gastric cancer cell
transference and invasion through regulating and controlling the
expression of miR-144/c-Met axis. Asian Pac J Trop Med. 9:508–512.
2016. View Article : Google Scholar : PubMed/NCBI
|
